Tumor cells rely on escaping immune surveillance to continuously grow and develop; therefore, it is critical to better understand how Sirt2 not only affects the tumor microenvironment, but whether it plays a role in the normal immune response, and if this role is intrinsic to the immune system or to the tumor of origin. The gene discussed is SIRT2; the disease is neoplasm.